How We Manage Hyperferritinemic Sepsis-Related Multiple Organ Dysfunction Syndrome/Macrophage Activation Syndrome/Secondary Hemophagocytic Lymphohistiocytosis Histiocytosis.
about
Hemophagocytic lymphohistiocytosis: an update for nephrologists.Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia.Interleukin 1 Receptor Antagonist Anakinra, Intravenous Immunoglobulin, and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis.
P2860
How We Manage Hyperferritinemic Sepsis-Related Multiple Organ Dysfunction Syndrome/Macrophage Activation Syndrome/Secondary Hemophagocytic Lymphohistiocytosis Histiocytosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
How We Manage Hyperferritinemi ...... hohistiocytosis Histiocytosis.
@en
How We Manage Hyperferritinemi ...... hohistiocytosis Histiocytosis.
@nl
type
label
How We Manage Hyperferritinemi ...... hohistiocytosis Histiocytosis.
@en
How We Manage Hyperferritinemi ...... hohistiocytosis Histiocytosis.
@nl
prefLabel
How We Manage Hyperferritinemi ...... hohistiocytosis Histiocytosis.
@en
How We Manage Hyperferritinemi ...... hohistiocytosis Histiocytosis.
@nl
P2093
P2860
P1476
How We Manage Hyperferritinemi ...... hohistiocytosis Histiocytosis.
@en
P2093
Bradley S Podd
Dennis W Simon
Joseph A Carcillo
P2860
P304
P356
10.1097/PCC.0000000000000460
P577
2015-07-01T00:00:00Z